Top Markets
#1 Velas Velas +562.78%
#2 Polymath Polymath +529.94%
#3 Galxe Galxe +96.05%
#4 XION XION +63.34%
#5 Resolv wstUSR Resolv wstUSR +59.11%
#6 Nomina Nomina +45.78%
#7 Cofinex Cofinex +26.87%
#8 Swarms Swarms +16.74%
#9 Unibase Unibase +15.72%
#10 Cysic Cysic +14.51%
Coin of the day
Velas Velas
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Exscientia plc Exscientia plc

Exscientia plc

EXAI
Pozycja w akcjach #99999
Exscientia plc, an artificial intelligence-driven pharmatech company, engages... Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Cena akcji
$4.84
Kapitalizacja rynkowa
$633.18M
Zmiana (1 dzień)
3.20%
Zmiana (1 rok)
0.00%
Kraj
GB
Handel Exscientia plc (EXAI)

Kategoria

Healthcare
Wskaźnik P/S dla Exscientia plc (EXAI)
Wskaźnik P/S na dzień April 2026 TTM: 23.78
Według najnowszych raportów finansowych i ceny akcji Exscientia plc, obecny wskaźnik P/S (TTM) wynosi 23.78. Na koniec 2022 wynosił 24.27.
Historia wskaźnika P/S dla Exscientia plc od 2019 do 2026
Wskaźnik P/S na koniec każdego roku
Rok Wskaźnik P/S Zmień
2026 (TTM) 23.78 -23.72%
2023 31.18 28.46%
2022 24.27 -72.05%
2021 86.85 -52.06%
2020 181.16 -12.07%
2019 206.03 0.00%
Wskaźnik P/S dla podobnych firm lub konkurentów
Firma Wskaźnik P/S Różnica wskaźnika P/S Kraj
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
3.32 -86.04%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.42 -60.38%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
5.60 -76.47%
US
UCB SA UCB SA
UCB SA
UCB.BR
6.36 -73.27%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.04 -87.22%
AU